Avatar

About Admin@gbi

This author has not yet filled in any details.
So far Admin@gbi has created 340 blog entries.

A GBI intern’s perspective on attending the 2018 United Nations General Assembly events in NYC

Rasita Vinay, M. Bioethics Candidate, GBI Intern My ongoing internship with Global Bioethics Initiative (GBI), a not-for-profit international organisation in consultative status with the United Nations ECOSOC, has given me exposure to some pressing global health and bioethical issues through the 2018 International Bioethics Summer School, as well as to some of the 73rd United [...]

By |2020-04-09T23:42:49+00:00October 3rd, 2018|News-Articles|0 Comments

Secretary-General of the United Nations Speaking at a UNESCO event at the UNGA on the Case of Anti-Semitism

GBI staff and interns attended several high-level events at the 73rd session of the General Assembly including the General Debate. The Power of Education for Countering Racism and Discrimination: The case of anti-Semitism 26 Sep 2018 -  Racism and discrimination are global issues, as is anti-Semitism: wherever it expresses itself, it is a symptom of broader [...]

By |2020-04-09T23:42:58+00:00September 28th, 2018|News-Articles|0 Comments

Creating Designer Babies Using Posthumous Sperm

Rasita Vinay, M. Bioethics Candidate, GBI Intern The pioneering of in vitro fertilisation (IVF) in 1977 has greatly helped women around the world to overcome their infertility issues. From providing women with a chance to become pregnant, to its continuous advancement in embryo research and the development of other assisted reproductive technology (ART), IVF is [...]

By |2018-09-29T17:28:16+00:00September 22nd, 2018|News-Articles|1 Comment

For the Living, a Donated Face. For the Dead, a Lifelike Replacement.

NYU surgeons hope a 3-D printed reproduction will encourage people to donate the faces of dying family members for use as transplants. By ANDY NEWMAN and MARC SANTORA JAN. 5, 2018 Most medical advances benefit the living. This one is for the dead. Sometime in the coming weeks or months, a brain-dead person, probably a man, will be wheeled [...]

By |2020-04-09T23:43:11+00:00January 9th, 2018|News-Articles|2 Comments

GBI excited to ​announce new President, Dr. Bruce Gelb

Global Bioethics Initiative is pleased to announce the election of Dr. Bruce Gelb, M.D., F.A.C.S, as President of the Board of Directors. Dr. Gelb is an Assistant Professor of Surgery at NYU Langone Medical Center, School of Medicine, and the Surgical Director of Renal Transplantation of the NYU Langone Transplant Institute. He also performs liver [...]

By |2020-04-09T23:45:16+00:00December 13th, 2016|News-Articles|0 Comments

​​​The future of ​b​ioethics under President-elect Trump: Professor ​​Moreno​’s Thoughts​

It is difficult to predict the fate of bioethics in the coming years under the new President-elect Trump, states Professor Jonathan Moreno, an Advisory Board member of Global Bioethics Initiative.  He is also a Professor of Medical Ethics and Health Policy, History and Sociology of Science, and of Philosophy. In 2008-09 he served as a member [...]

By |2020-04-09T23:45:21+00:00November 16th, 2016|News-Articles|0 Comments

After the election bioethics faces a rocky road

By Arthur Caplan Academic bioethics has never been popular with Republicans. Libertarians dislike academic bioethics because it seems too elitist and anti-free market.  Religious thinkers worry it is technocratic, soulless and crassly utilitarian. Now with Trumpism add a populist disdain for expertise, experts and the scientific method and you have a stew that means few [...]

By |2020-04-09T23:45:23+00:00November 11th, 2016|News-Articles|0 Comments

Novel system to get dying patients an experimental cancer drug raises hopes — and thorny questions

By KAREN WEINTRAUB @kweintraub NOVEMBER 8, 2016 The drug was still experimental, but clinical trials suggested it could be a lifesaver for patients with a lethal form of blood cancer called multiple myeloma. And those patients were clamoring to get it. They overwhelmed drug maker Janssen Pharmaceuticals with requests for the medication. Most companies [...]

By |2020-04-09T23:45:25+00:00November 11th, 2016|News-Articles|0 Comments